Literature DB >> 23722324

Oligoclonal bands in multiple sclerosis reactive against two herpesviruses and association with magnetic resonance imaging findings.

J O Virtanen1, J Wohler, K Fenton, D S Reich, S Jacobson.   

Abstract

BACKGROUND: Two human herpesviruses, human herpesvirus 6 (HHV-6), and Epstein-Barr virus (EBV), have been repeatedly linked to multiple sclerosis (MS).
OBJECTIVE: The aim of this study was to investigate HHV-6 and EBV reactive oligoclonal bands (OCBs), and viral DNA in the intrathecal compartment in MS.
METHODS: The reactivity of OCBs in cerebrospinal fluid (CSF) for EBV and HHV-6 antigens and stability of virus reactive OCBs over time were studied in a well-characterized MS patient cohort. Associations between virus reactive OCBs and viral DNA in CSF (and any clinical and/or radiological findings) were investigated.
RESULTS: Of patients with MS, 38% had OCBs reactive to either one of the viruses studied, compared to none in the patients with other inflammatory neurological diseases (p=0.005). The banding pattern of virus reactive OCBs remained the same over time. Furthermore, MS patients with viral DNA in CSF had more contrast enhancing lesions (CELs).
CONCLUSION: The stable presence of herpesvirus reactive OCBs in CSF further strengthens the association of MS with these viruses. The finding that herpesviruses might be linked to the appearance of active lesions warrants investigation of new therapeutic strategies to treat these viruses in MS.

Entities:  

Keywords:  Multiple sclerosis; immunology; magnetic resonance imaging

Mesh:

Substances:

Year:  2013        PMID: 23722324      PMCID: PMC5001156          DOI: 10.1177/1352458513490545

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  36 in total

1.  Intrathecal immune responses to EBV in early MS.

Authors:  Emilie Jaquiéry; Samantha Jilek; Myriam Schluep; Pascal Meylan; Andreas Lysandropoulos; Giuseppe Pantaleo; Renaud A Du Pasquier
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

2.  Intrathecal human herpesvirus 6 antibodies in multiple sclerosis and other demyelinating diseases presenting as oligoclonal bands in cerebrospinal fluid.

Authors:  Jussi O Virtanen; Jenna Pietiläinen-Nicklén; Lasse Uotila; Markus Färkkilä; Antti Vaheri; Marjaleena Koskiniemi
Journal:  J Neuroimmunol       Date:  2011-07-20       Impact factor: 3.478

3.  CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity.

Authors:  M J Reddehase; W Mutter; K Münch; H J Bühring; U H Koszinowski
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

Review 4.  Environmental factors and their timing in adult-onset multiple sclerosis.

Authors:  Adam E Handel; Gavin Giovannoni; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Neurol       Date:  2010-02-16       Impact factor: 42.937

5.  Low intrathecal immune response of anti-EBNA-1 antibodies and EBV DNA from multiple sclerosis patients.

Authors:  Enrique Villegas; Olivia Santiago; Jose Antonio Carrillo; Antonio Sorlózano; Miguel Guerrero; Oscar Fernández; José Gutiérrez
Journal:  Diagn Microbiol Infect Dis       Date:  2011-03-09       Impact factor: 2.803

6.  Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients.

Authors:  R Alvarez-Lafuente; M García-Montojo; V De Las Heras; M I Domínguez-Mozo; M Bartolome; M S Benito-Martin; R Arroyo
Journal:  Mult Scler       Date:  2008-06       Impact factor: 6.312

7.  Viral antibody activity of oligoclonal and polyclonal immunoglobulins synthesized within the central nervous system in multiple sclerosis.

Authors:  B Roström; H Link; M A Laurenzi; S Kam-Hansen; E Norrby; B Wahren
Journal:  Ann Neurol       Date:  1981-06       Impact factor: 10.422

8.  Distribution and quantification of human herpesvirus 6 in multiple sclerosis and control brains.

Authors:  P W Tuke; S Hawke; P D Griffiths; D A Clark
Journal:  Mult Scler       Date:  2004-08       Impact factor: 6.312

9.  Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients - follow-up and clinical implications.

Authors:  Hela-Felicitas Petereit; Dirk Reske
Journal:  Cerebrospinal Fluid Res       Date:  2005-06-27

10.  Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: diagnostic and therapeutic implications.

Authors:  J O Virtanen; M Färkkilä; J Multanen; L Uotila; A J Jääskeläinen; A Vaheri; M Koskiniemi
Journal:  J Neurovirol       Date:  2007-08       Impact factor: 3.739

View more
  21 in total

1.  Human Herpesvirus 6 Detection in Alzheimer's Disease Cases and Controls across Multiple Cohorts.

Authors:  Mary Alice Allnutt; Kory Johnson; David A Bennett; Sarah M Connor; Juan C Troncoso; Olga Pletnikova; Marilyn S Albert; Susan M Resnick; Sonja W Scholz; Philip L De Jager; Steven Jacobson
Journal:  Neuron       Date:  2020-01-23       Impact factor: 17.173

2.  Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barré syndrome.

Authors:  Diana Ferraro; Veronica Galli; Anna Maria Simone; Roberta Bedin; Francesca Vitetta; Elisa Merelli; Paolo Frigio Nichelli; Patrizia Sola
Journal:  J Neurovirol       Date:  2016-11-22       Impact factor: 2.643

Review 3.  Viruses in chronic progressive neurologic disease.

Authors:  Emily C Leibovitch; Steven Jacobson
Journal:  Mult Scler       Date:  2018-01       Impact factor: 6.312

4.  Prevalence of human Herpesviridae in cerebrospinal fluid of patients with multiple sclerosis and noninfectious neurological disease in the Netherlands.

Authors:  Gijsbert P van Nierop; Rogier Q Hintzen; Georges M G M Verjans
Journal:  J Neurovirol       Date:  2014-03-27       Impact factor: 2.643

5.  Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: A case-controlled magnetization transfer ratio study.

Authors:  Dejan Jakimovski; Murali Ramanathan; Bianca Weinstock-Guttman; Niels Bergsland; Deepa P Ramasamay; Ellen Carl; Michael G Dwyer; Robert Zivadinov
Journal:  Mult Scler       Date:  2019-02-13       Impact factor: 6.312

Review 6.  Evidence linking HHV-6 with multiple sclerosis: an update.

Authors:  Emily C Leibovitch; Steven Jacobson
Journal:  Curr Opin Virol       Date:  2014-10-17       Impact factor: 7.090

Review 7.  Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation.

Authors:  Anthony L Komaroff; Philip E Pellett; Steven Jacobson
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

8.  Presence of Epstein-Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammation.

Authors:  Tommaso Lupia; Maria Grazia Milia; Cristiana Atzori; Sara Gianella; Sabrina Audagnotto; Daniele Imperiale; Lorenzo Mighetto; Veronica Pirriatore; Gabriella Gregori; Filippo Lipani; Valeria Ghisetti; Stefano Bonora; Giovanni Di Perri; Andrea Calcagno
Journal:  AIDS       Date:  2020-03-01       Impact factor: 4.632

9.  FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.

Authors:  Caroline A Blanc; Hugh Rosen; Thomas E Lane
Journal:  J Neuroinflammation       Date:  2014-08-20       Impact factor: 8.322

Review 10.  HSV-1 and Endogenous Retroviruses as Risk Factors in Demyelination.

Authors:  Raquel Bello-Morales; Sabina Andreu; Inés Ripa; José Antonio López-Guerrero
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.